Yanchuang Capital
Yanchuang Capital is a venture capital firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Yanchuang Capital Information
Geographic Data
Address: No.17 Ritan North Road,
City: Beijing
State: shanghai municipality
Zip: 100000
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
"Yan Chuang Capital", the full name of "Yanyuan Innovation Capital Group", was founded in June 2010, formerly known as "Yanyuan Capital Group". A high-tech enterprise investment and capital operation platform co-sponsored by Peking University alumni who have transformed achievements. Yanchuang Capital always takes value investment as the core, adhering to the corporate philosophy of "Integrity and character, customer-centered, and ultimate work", based on the excavation of China&s;s outstanding achievements in the historical trend of economic growth, technological catch-up, and corporate growth. Enterprises and entrepreneurs; take capital as the main channel and provide empowerment services, and create greater value for investors through common growth and win-win development with outstanding enterprises and entrepreneurs.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2017 | Tiande Technology | Angel Round | 435.8k |
| 3/2018 | Shentong | Series A | 1.6M |
| 3/2022 | TenNor Therapeutics | Series D | 0 |
| 8/2015 | Feichang Danao | Angel Round | 1.6M |
| 5/2022 | Laekna Therapeutics | Series D | 0 |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 12/2022 | TenNor Therapeutics | Series D | 9.5M |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 6/2020 | Asieris Pharmaceuticals | Series C | 41M |
| 3/2021 | Lingdi Technology | Series B | 0 |
| 3/2020 | Asieris Pharmaceuticals | Series C | 14.2M |
| 4/2021 | SceneRay | Series D | - |
| 8/2021 | Compson Agricultural Technology | Venture Round | 15.4M |
| 2/2020 | Lingdi Technology | Series A | 0 |
| 3/2021 | Style3D | Series B | 30.8M |
| 5/2022 | Laekna Therapeutics | Series D | 0 |
| 3/2022 | TenNor Therapeutics | Series D | 0 |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 8/2021 | Compson Agricultural Technology | Venture Round | 0 |
| 4/2021 | SceneRay | Series D | - |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 3/2021 | Lingdi Technology | Series B | 0 |
| 6/2020 | Asieris Pharmaceuticals | Series C | 0 |
| 3/2020 | Asieris Pharmaceuticals | Series C | 0 |
| 2/2020 | Lingdi Technology | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
